Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-191657
Filing Date
2012-04-27
Accepted
2012-04-27 17:15:10
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d341123d10ka.htm 10-K/A 506510
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION d341123dex31.htm EX-3.1 18947
3 AMENDED AND RESTATED BYLAWS d341123dex32.htm EX-3.2 48179
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER, AS REQUIRED BY SECTION 302 d341123dex313.htm EX-31.3 3632
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER, AS REQUIRED BY SECTION 302 d341123dex314.htm EX-31.4 3623
  Complete submission text file 0001193125-12-191657.txt   581869
Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Filer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35189 | Film No.: 12790981
SIC: 2860 Industrial Organic Chemicals